BIOAF (Bioasis Technologies) OCF Yield %: -39,600.00 (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BIOAF Bioasis Technologies Inc BIOAF
12 GF Score
Price $0.00
View Full Analysis

What is Bioasis Technologies OCF Yield %?

Bioasis Technologies BIOAF 12 OCF Yield % is -39,600.00 as of Jul. 14, 2026. GuruFocus rates BIOAF with a GF Score™ of 12/100.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Bioasis Technologies's Trailing 12-Month Cash Flow from Operations is $-1.50 Mil, and Market Cap is $0.00 Mil. Therefore, Bioasis Technologies's OCF Yield % for today is -39,600.00%.

The historical rank and industry rank for Bioasis Technologies's OCF Yield % or its related term are showing as below:

BIOAF' s OCF Yield % Range Over the Past 10 Years
Min: -9814000   Med: 0   Max: 314.29
Current: -39600

During the past 13 years, the highest OCF Yield % of Bioasis Technologies was 314.29%. The lowest was -9814000.00%. And the median was %.

BIOAF's OCF Yield % is not ranked
in the Biotechnology industry.
Industry Median: -8.34 vs BIOAF: -39600.00

Bioasis Technologies's OCF Margin % for the quarter that ended in Nov. 2022 was %.

Bioasis Technologies OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Bioasis Technologies OCF Yield % Related Terms

Bioasis Technologies OCF Yield % Historical Data

* Premium members only.

The historical data trend for Bioasis Technologies's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioasis Technologies OCF Yield % Chart

Bioasis Technologies Annual Data
Trend Feb13 Feb14 Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.11 -12.63 -22.33 6.45 -18.78

Bioasis Technologies Quarterly Data
Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.64 -14.08 -13.17 -6.97 -13.32

BIOAF vs VRTX, REGN, SGEN: OCF Yield % Comparison

For the Biotechnology subindustry, Bioasis Technologies's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioasis Technologies OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioasis Technologies's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Bioasis Technologies's OCF Yield % falls into.


BIOAF
12GF Score
Bioasis Technologies Inc BIOAF
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioasis Technologies OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Bioasis Technologies's OCF Yield % for the fiscal year that ended in Feb. 2022 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-2.861 / 15.2317346
=-18.78%

Bioasis Technologies's annualized OCF Yield % for the quarter that ended in Nov. 2022 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-0.329 * 4 / 9.8791016
=-13.32%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -39,600.00 mean?
Bioasis Technologies (BIOAF) has a OCF Yield % of -39,600.00 as of Jul. 14, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Bioasis Technologies and its competitors.
Is Bioasis Technologies' OCF Yield % too high?
Bioasis Technologies' current OCF Yield % is -39,600.00. Overall, Bioasis Technologies has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bioasis Technologies' OCF Yield % compare to VRTX and REGN?
Bioasis Technologies' OCF Yield % of -39,600.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Bioasis Technologies and its competitors. Bioasis Technologies's current OCF Yield % is -39,600.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioasis Technologies stock overvalued right now?
Bioasis Technologies (BIOAF) has a current OCF Yield % of -39,600.00. The current OCF Yield % is -39,600.00. Bioasis Technologies' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Bioasis Technologies (BIOAF), the current OCF Yield % is -39,600.00 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioasis Technologies Business Description

Address 157 Church Street, 19th Floor, New Haven, CT, USA, 06510
Bioasis Technologies Inc is a development stage biopharmaceutical company engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company's xB3 program describes its proprietary carrier, p97, and components thereof, to deliver therapeutics across the blood-brain barrier (BBB).
12GF Score

Get the complete analysis for BIOAF

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price